Health Advocates Call for Update to India's Essential Medicines List
Health groups are urging the Indian government to revise the National List of Essential Medicines (NLEM). The current NLEM, last updated in 2022, includes 384 medicines. In contrast, the World Health Organization (WHO) has updated its Model List of Essential Medicines twice since then, in 2023 and again in 2025. The WHO's latest list now comprises 523 medicines. The Working Group on Access to Medicines and Treatments highlighted this discrepancy, emphasizing the need for India's list to reflect current global standards and advancements in medical treatment. An updated NLEM is crucial for ensuring that essential drugs are accessible and affordable to the Indian population, aligning with international best practices in public health.
The call to update India's National List of Essential Medicines (NLEM) highlights a common challenge in public health systems: maintaining alignment with rapidly evolving global medical knowledge and pharmaceutical innovation. The discrepancy in the number of medicines between India's current list and the WHO's updated model list suggests potential delays in incorporating newer, potentially more effective treatments into national drug formularies. This could impact patient access to optimal care and create inefficiencies in procurement and distribution. Future-proofing such lists requires robust, agile governance mechanisms that can systematically review and integrate new evidence and therapies, balancing cost-effectiveness with the imperative of providing up-to-date medical interventions in the context of advancing healthcare technologies and global health standards.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.